Lindbrook Capital, LLC Glaukos Corp Transaction History
Lindbrook Capital, LLC
- $1.18 Billion
- Q3 2024
A detailed history of Lindbrook Capital, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 87 shares of GKOS stock, worth $12,544. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 76
14.47%
Holding current value
$12,544
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GKOS
# of Institutions
342Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.16 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$847 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$315 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$282 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$236 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.86B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...